For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.
What is the forecasted revenue size of the ready-to-use luria-bertani (lb) liquid medium industry by 2029?
The ready-to-use luria-bertani (LB) liquid medium market size has grown strongly in recent years. It will grow from $10.32 billion in 2024 to $11.21 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to growing adoption in pharmaceutical and biotechnology sectors, growing demand for advanced medicines, increasing demand for microbiological research, rising demand for outsourcing R&D activities, and increasing demand for microbiological research.
The ready-to-use luria-bertani (LB) liquid medium market size is expected to see strong growth in the next few years. It will grow to $15.4 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growing adoption in pharmaceutical and biotechnology sectors, growing demand for advanced medicines, increasing demand for microbiological research, rising demand for outsourcing R&D activities, increasing demand for microbiological research. Major trends in the forecast period include advancements in customization and packaging, increasing research and development activities, increasing demand for standardized media, rising adoption of automated laboratory systems, and growing preference for pre-formulated solutions.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20611&type=smp
Which industry-specific innovations are acting as key drivers for the ready-to-use luria-bertani (lb) liquid medium market?
The increasing research and development activities are expected to propel the growth of the ready-to-use Luria-Bertani (LB) liquid medium market going forward. Research and development activities encompass investigating new ideas or technologies and using the results to build or improve goods or processes through design, testing, and refining. The objectives of continuous innovation force businesses to engage in R and D to create new products, improve old ones, and remain competitive by satisfying changing consumer needs. Ready-to-use LB liquid medium is an important component in R and D because it promotes bacterial growth, gene cloning, protein expression, and other genetic modifications. Its convenience and dependability make it essential for a variety of experimental techniques and large-scale research applications. For instance, in September 2023, according to the National Center for Science and Engineering Statistics, a US-based statistical agency, federal agency obligations for research and experimental development (R&D) hit a record high of $190.2 billion, marking a 13.6% increase ($22.7 billion) from 2021. Therefore, increasing research and development activities drive the ready-to-use Luria-Bertani (LB) liquid medium market.
Ready-to-Use Luria-Bertani (LB) Liquid Medium Market Driver: Surge In Clinical Trials Boosts The Ready-To-Use LB Liquid Medium Market
The rising number of clinical trials is expected to propel the growth of the ready-to-use Luria-Bertani (LB) liquid medium market going forward. A clinical trial is a research study involving human participants to assess the safety and effectiveness of a new medical intervention before it is approved for general use. The surge in clinical trials is driven by the demand for personalized medicine, which aims to create treatments customized for individual genetic profiles and specific health conditions. Clinical trials demand consistent conditions for accurate results, and ready-to-use LB liquid medium ensures this reliability without the need for preparation or sterilization. This efficiency speeds up the research process, particularly in high-throughput and multi-site studies. For instance, in November 2023, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based non-profit organization that produces prescription medicines for human use, the number of industry clinical trials initiated in the UK rose by 4.3%, from 394 in 2021 to 411 in 2022. Therefore, the rising number of clinical trials drives the ready-to-use Luria-Bertani (LB) liquid medium market.
Which segment currently leads the ready-to-use luria-bertani (lb) liquid medium market in terms of revenue share?
The ready-to-use luria-bertani (LB) liquid medium market covered in this report is segmented –
1) By Type: Contains Antibiotics, Antibiotic Free
2) By Application: Drug Discovery, Stem Cell Technologies, Regenerative Medicine And Tissue Engineering, Bio-Pharmaceuticals, Cancer Research, Other Applications
3) By End-User: Research Laboratories, Academic Institutes, Biotechnology And Pharmaceutical Sector, Other End-Users
Subsegments:
1) By Contains Antibiotics: LB Medium With Ampicillin, LB Medium With Kanamycin, LB Medium With Tetracycline, LB Medium With Chloramphenicol, LB Medium With Streptomycin
2) By Antibiotic Free: Standard LB Liquid Medium, LB Liquid Medium With Supplementary Nutrients, LB Liquid Medium For Fast-Growing Bacteria, LB Liquid Medium For Low-Temperature Growth
View The Full Market Report:
What future trends will impact the direction of the ready-to-use luria-bertani (lb) liquid medium industry?
Major companies operating in the ready-to-use Luria-Bertani (LB) liquid medium market are focusing on advancements in drug discovery software to gain a competitive edge. For instance, in December 2023, Merck, a Germany-based pharmaceuticals and biotechnology products company, launched AIDDISON, a cutting-edge drug discovery software that utilizes artificial intelligence and machine learning algorithms to accelerate the identification of potential drug candidates. AIDDISON features a user-friendly interface and advanced data analysis capabilities, allowing researchers to efficiently process and interpret large volumes of data. This innovative software has the potential to revolutionize the drug discovery process, ultimately leading to faster and more cost-effective development of new therapeutics.
Who are the top competitors in the global ready-to-use luria-bertani (lb) liquid medium market?
Major companies operating in the ready-to-use luria-bertani (LB) liquid medium market are Thermo Fisher Scientific Inc., Avantor Inc., Lonza Group AG, Sigma Aldrich Chemicals Pvt. Ltd., Bio-Rad Laboratories Inc., Neogen Corporation, bioWORLD, Hardy Diagnostics Inc., MP Biomedicals LLC, ITW Reagents, Alpha Teknova Inc., HiMedia Laboratories Pvt. Ltd., Scharlab S.L., Interchim, Condalab, Quality Biological Inc., Thomas Scientific LLC, Geno Technology Inc., Central Drug House (P) Ltd., Citotest Labware Manufacturing Co. Ltd., Research Products International, NZYTech Lda
What regional dynamics are shaping the future of the global ready-to-use luria-bertani (lb) liquid medium market?
Europe was the largest region in the ready-to-use Luria-Bertani (LB) liquid medium market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ready-to-use Luria-bertani (LB) liquid medium market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Ready-To-Use Luria-Bertani (LB) Liquid Medium Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20611
Need Customized Data On Ready-To-Use Luria-Bertani (LB) Liquid Medium Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20611&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
